These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Construction of Discrimination Models of Cationic Drugs for Phospholipidosis Induction Potential by Using Interaction Data with Immobilized Artificial Membrane as Well as Physicochemical Properties. Iwakuma Y; Kuroda Y J Pharm Sci; 2024 May; ():. PubMed ID: 38734209 [TBL] [Abstract][Full Text] [Related]
4. Using artificial neural networks to accelerate flowsheet optimization for downstream process development. Keulen D; Hagen EV; Geldhof G; Le Bussy O; Pabst M; Ottens M Biotechnol Bioeng; 2024 Aug; 121(8):2318-2331. PubMed ID: 37256724 [TBL] [Abstract][Full Text] [Related]
5. Immobilized Keratin HPLC Stationary Phase-A Forgotten Model of Transdermal Absorption: To What Molecular and Biological Properties Is It Relevant? Sobańska AW; Brzezińska E Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111656 [TBL] [Abstract][Full Text] [Related]
6. Quantitative Structure-Retention Relationship Analysis of Polycyclic Aromatic Compounds in Ultra-High Performance Chromatography. Ruggieri F; Biancolillo A; D'Archivio AA; Di Donato F; Foschi M; Maggi MA; Quattrociocchi C Molecules; 2023 Apr; 28(7):. PubMed ID: 37049982 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Lipophilicity Parameters of Antimicrobial and Immunosuppressive Compounds. Wardecki D; Dołowy M; Bober-Majnusz K Molecules; 2023 Mar; 28(6):. PubMed ID: 36985792 [TBL] [Abstract][Full Text] [Related]
8. Quantitative Structure Retention-Relationship Modeling: Towards an Innovative General-Purpose Strategy. Kumari P; Van Laethem T; Hubert P; Fillet M; Sacré PY; Hubert C Molecules; 2023 Feb; 28(4):. PubMed ID: 36838689 [TBL] [Abstract][Full Text] [Related]
9. Affinity of Compounds for Phosphatydylcholine-Based Immobilized Artificial Membrane-A Measure of Their Bioconcentration in Aquatic Organisms. Sobańska AW Membranes (Basel); 2022 Nov; 12(11):. PubMed ID: 36422122 [TBL] [Abstract][Full Text] [Related]
10. Immobilized artificial membrane chromatography: quantitative structure-retention relationships of structurally diverse drugs. Luco JM; Salinas AP; Torriero AA; Vázquez RN; Raba J; Marchevsky E J Chem Inf Comput Sci; 2003; 43(6):2129-36. PubMed ID: 14632465 [TBL] [Abstract][Full Text] [Related]
12. Recent developments in the application of immobilized artificial membrane (IAM) chromatography to drug discovery. Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A Expert Opin Drug Discov; 2024 Jul; ():1-12. PubMed ID: 38957047 [TBL] [Abstract][Full Text] [Related]
13. Predictions of peptides' retention times in reversed-phase liquid chromatography as a new supportive tool to improve protein identification in proteomics. Baczek T; Kaliszan R Proteomics; 2009 Feb; 9(4):835-47. PubMed ID: 19160394 [TBL] [Abstract][Full Text] [Related]
14. Prediction of the chromatographic hydrophobicity index with immobilized artificial membrane chromatography using simple molecular descriptors and artificial neural networks. Ciura K; Kovačević S; Pastewska M; Kapica H; Kornela M; Sawicki W J Chromatogr A; 2021 Dec; 1660():462666. PubMed ID: 34781046 [TBL] [Abstract][Full Text] [Related]